Detalles de la búsqueda
1.
Designing a decision aid for cancer prevention: a qualitative study.
Fam Pract
; 2023 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058423
2.
Delayed or failure to follow-up abnormal breast cancer screening mammograms in primary care: a systematic review.
BMC Cancer
; 21(1): 373, 2021 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33827476
3.
Long-term consumer involvement in cancer research: Working towards partnership.
Health Expect
; 24(4): 1263-1269, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33949071
4.
The CRISP-P study: feasibility of a self-completed colorectal cancer risk prediction tool in primary care.
Fam Pract
; 36(6): 730-735, 2019 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31237329
5.
Should I Take Aspirin? (SITA): RCT of a decision aid for cancer chemoprevention.
Br J Gen Pract
; 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38527793
6.
Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial.
Br J Gen Pract
; 74(741): e275-e282, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164588
7.
The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening.
Br J Gen Pract
; 73(733): e556-e565, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37012077
8.
SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
Trials
; 24(1): 723, 2023 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957680
9.
Informed choice and attitudes regarding a genomic test to predict risk of colorectal cancer in general practice.
Patient Educ Couns
; 105(4): 987-995, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34400040
10.
The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
Trials
; 23(1): 31, 2022 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35022080
11.
The Impact of a Comprehensive Risk Prediction Model for Colorectal Cancer on a Population Screening Program.
JNCI Cancer Spectr
; 4(5): pkaa062, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33134836
12.
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study.
PLoS One
; 15(3): e0229999, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32142536
13.
A Genomic Test for Colorectal Cancer Risk: Is This Acceptable and Feasible in Primary Care?
Public Health Genomics
; 23(3-4): 110-121, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32688362
14.
Decision support tools to improve cancer diagnostic decision making in primary care: a systematic review.
Br J Gen Pract
; 69(689): e809-e818, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31740460
15.
Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.
Br J Gen Pract
; 69(689): e836-e842, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31636127
Resultados
1 -
15
de 15
1
Próxima >
>>